Tg Therapeutics (TGTX) Other Gross PP&E Adjustments (2019 - 2025)
Tg Therapeutics has reported Other Gross PP&E Adjustments over the past 7 years, most recently at -$6.3 million for Q4 2025.
- Quarterly results put Other Gross PP&E Adjustments at -$6.3 million for Q4 2025, up 11.9% from a year ago — trailing twelve months through Dec 2025 was -$6.3 million (up 11.9% YoY), and the annual figure for FY2025 was -$6.3 million, up 11.9%.
- Other Gross PP&E Adjustments for Q4 2025 was -$6.3 million at Tg Therapeutics, up from -$6.5 million in the prior quarter.
- Over the last five years, Other Gross PP&E Adjustments for TGTX hit a ceiling of -$6.3 million in Q4 2025 and a floor of -$9.1 million in Q1 2021.
- Median Other Gross PP&E Adjustments over the past 5 years was -$8.4 million (2023), compared with a mean of -$8.1 million.
- Biggest five-year swings in Other Gross PP&E Adjustments: dropped 3.36% in 2022 and later increased 12.38% in 2025.
- Tg Therapeutics' Other Gross PP&E Adjustments stood at -$8.6 million in 2021, then dropped by 3.0% to -$8.9 million in 2022, then grew by 9.43% to -$8.0 million in 2023, then grew by 11.17% to -$7.2 million in 2024, then rose by 11.9% to -$6.3 million in 2025.
- The last three reported values for Other Gross PP&E Adjustments were -$6.3 million (Q4 2025), -$6.5 million (Q3 2025), and -$6.7 million (Q2 2025) per Business Quant data.